These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 766340)

  • 41. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K; Kruty R; Matula F; Badalik L
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract]   [Full Text] [Related]  

  • 42. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ
    Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
    [No Abstract]   [Full Text] [Related]  

  • 44. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical evaluation of rifampicin for pulmonary tuberculosis. 3. A controlled trial on the clinical effects of chemotherapy with rifampicin-ethambutol and viomycin-ethambutol in retreatment cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1971 Sep; 46(9):371-7. PubMed ID: 4330662
    [No Abstract]   [Full Text] [Related]  

  • 46. [Assessment of the use of a multicomponent drug in the treatment of new cases of pulmonary tuberculosis].
    Semenova OV
    Probl Tuberk Bolezn Legk; 2003; (11):22-5. PubMed ID: 14689793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis.
    Castelo A; Jardim JR; Goihman S; Kalckman AS; Dalboni MA; da Silva EA; Haynes RB
    Lancet; 1989 Nov; 2(8673):1173-6. PubMed ID: 2572899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 52. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].
    Mazouni L; Tazir M; Boulahbal F; Chaulet P
    Rev Mal Respir; 1985; 2(4):209-14. PubMed ID: 3937189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
    Horsfall PA
    Tubercle; 1972 Sep; 53(3):166-73. PubMed ID: 4116994
    [No Abstract]   [Full Text] [Related]  

  • 55. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W
    Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modern management of tuberculosis.
    Promisloff RA; Johnston RF
    Compr Ther; 1979 Oct; 5(10):25-37. PubMed ID: 498742
    [No Abstract]   [Full Text] [Related]  

  • 57. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 59. Importance of rifampicin in combined daily/intermittent chemotherapy for tuberculosis.
    Felten MK
    S Afr Med J; 1989 Jun; 75(11):524-6. PubMed ID: 2727841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
    Tubercle; 1977 Mar; 58(1):1-8. PubMed ID: 325837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.